Nothing Special   »   [go: up one dir, main page]

EP0568539A4 - Soluble mannose receptor peptides - Google Patents

Soluble mannose receptor peptides

Info

Publication number
EP0568539A4
EP0568539A4 EP19920900254 EP92900254A EP0568539A4 EP 0568539 A4 EP0568539 A4 EP 0568539A4 EP 19920900254 EP19920900254 EP 19920900254 EP 92900254 A EP92900254 A EP 92900254A EP 0568539 A4 EP0568539 A4 EP 0568539A4
Authority
EP
European Patent Office
Prior art keywords
mannose receptor
receptor peptides
soluble mannose
soluble
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19920900254
Other versions
EP0568539A1 (en
Inventor
Raymond Alan Brian Ezekowitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Medical Center Corp
Original Assignee
Childrens Medical Center Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center Corp filed Critical Childrens Medical Center Corp
Publication of EP0568539A1 publication Critical patent/EP0568539A1/en
Publication of EP0568539A4 publication Critical patent/EP0568539A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP19920900254 1990-11-06 1991-11-06 Soluble mannose receptor peptides Withdrawn EP0568539A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60991590A 1990-11-06 1990-11-06
US609915 1990-11-06
PCT/US1991/008320 WO1992007579A1 (en) 1990-11-06 1991-11-06 Soluble mannose receptor peptides

Publications (2)

Publication Number Publication Date
EP0568539A1 EP0568539A1 (en) 1993-11-10
EP0568539A4 true EP0568539A4 (en) 1994-07-06

Family

ID=24442877

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19920900254 Withdrawn EP0568539A4 (en) 1990-11-06 1991-11-06 Soluble mannose receptor peptides

Country Status (5)

Country Link
EP (1) EP0568539A4 (en)
JP (1) JPH06501620A (en)
AU (1) AU9040591A (en)
CA (1) CA2095729A1 (en)
WO (1) WO1992007579A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842297A1 (en) 1995-07-27 1998-05-20 IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY & MEDICINE Methods of predicting the outcome of infection
CN1106846C (en) 1997-08-21 2003-04-30 宝酒造株式会社 Carcinostatic agents
US7560534B2 (en) 2000-05-08 2009-07-14 Celldex Research Corporation Molecular conjugates comprising human monoclonal antibodies to dendritic cells
AU6138301A (en) 2000-05-08 2001-11-20 Medarex Inc Human monoclonal antibodies to dendritic cells
ZA200506202B (en) 2003-01-31 2006-10-25 Celldex Therapeutics Inc Antibody vaccine conjugates and uses therefor
US9259459B2 (en) 2003-01-31 2016-02-16 Celldex Therapeutics Inc. Antibody vaccine conjugates and uses therefor
EA026990B1 (en) 2007-11-07 2017-06-30 Селлдекс Терапьютикс Инк. Antibodies which bind to human cell dec-205
WO2010060632A1 (en) * 2008-11-27 2010-06-03 Bavarian Nordic A/S Promoters for recombinant viral expression
GB201717977D0 (en) * 2017-10-31 2017-12-13 Univ Court Of The Univ Of Aberdeen Treatment of anaemia
US20230365647A1 (en) 2020-06-30 2023-11-16 Zalvac Ab Mannose receptor-derived peptides for neutralizing pore-forming toxins for therapeutic uses

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001519A1 (en) * 1987-08-20 1989-02-23 Children's Hospital Corporation Human mannose binding protein

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1322972C (en) * 1988-03-07 1993-10-12 Pall Corporation Heaterless adsorption system for combined purification and fractionation of air

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001519A1 (en) * 1987-08-20 1989-02-23 Children's Hospital Corporation Human mannose binding protein

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9207579A1 *

Also Published As

Publication number Publication date
WO1992007579A1 (en) 1992-05-14
CA2095729A1 (en) 1992-05-07
AU9040591A (en) 1992-05-26
EP0568539A1 (en) 1993-11-10
JPH06501620A (en) 1994-02-24

Similar Documents

Publication Publication Date Title
GB9206757D0 (en) Novel peptide receptor ligands
GB9027249D0 (en) Offer matching system
HU911672D0 (en) Tfg-beta preparations
ZA915766B (en) Shampoo system
EP0491455A3 (en) Offer matching system
EP0448099A3 (en) Novel peptides
EP0568539A4 (en) Soluble mannose receptor peptides
ZA914933B (en) Receptor directed-toxin conjugates
EP0542920A4 (en) Cannabinoid receptor
ZA915978B (en) Peptides
EP0483066A3 (en) Soluble polyarylenethers
EP0521918A4 (en) Anti-tumour peptides
GB8905606D0 (en) Peptides
EP0451104A3 (en) Soluble polyarylenetherketones
GB9014652D0 (en) Antigen
GB9011069D0 (en) Combined garment-rail/decking-beam
GB9028140D0 (en) Peptides
GB9010740D0 (en) Peptide compounds and their preparation
MW891A1 (en) Polypeptides
GB9013773D0 (en) Polypeptides
GB9016215D0 (en) Polypeptides
GB9008361D0 (en) Modified peptide
GB9001030D0 (en) Peptide compounds
GB9005855D0 (en) Peptide compounds
GB9005854D0 (en) Peptide compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19930608

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE DK ES FR GB IT LI NL SE

RHK1 Main classification (correction)

Ipc: C12N 15/12

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE DK ES FR GB IT LI NL SE

RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 19940804

RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 19940804

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19961021